Stockreport

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF BOULDER, Colo., March 11, 2025 BUSINESS WIRE )--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that th [Read more]